Download PDF
Thromb Haemost 1974; 31(01): 086-102
DOI: 10.1055/s-0038-1649148
Original Article
Schattauer GmbH

Experimental Model of Pulmonary Thrombosis in Rat

Munehiro Tomikawa
1   Research Institute, Daiichi Seiyaku Co., Ltd., Edogawa-ku, Tokyo, Japan
,
Hidemasa Ogawa
1   Research Institute, Daiichi Seiyaku Co., Ltd., Edogawa-ku, Tokyo, Japan
,
Yasushi Abiko
1   Research Institute, Daiichi Seiyaku Co., Ltd., Edogawa-ku, Tokyo, Japan
› Author Affiliations
Further Information

Publication History

Received 01 September 1973

Accepted 03 October 1973

Publication Date:
29 June 2018 (online)

    Permissions and Reprints

Summary

Experimental pulmonary thrombosis was induced in rats by intravenous infusion of 0.7 M lactic acid at a rate of 1.4 ml/100 g/hr for 2 hr. As acidosis progressed, a hyper-coagulable state developed and microthrombi were formed predominantly in the lung, but not conspicuously in other organs. Pulmonary thrombi thus formed were composed of aggregated platelets in the initial stage, and of fibrin in later stages. They progressively dissolved and had completely disappeared 12 hr after cessation of the lactic acid infusion.

During the infusion of lactic acid, the following changes were observed: progressive decreases in platelet count, fibrinogen, antiplasmin activity and fibrinolytic activity, and progressive increase in platelet adhesiveness. Plasma clotting time decreased to its shortest interval after one hour of the lactic acid infusion and remained at that level during the rest of the infusion. No fibrin degradation products (FDP) were detected.

After cessation of the lactic acid infusion, these parameters, except for fibrinolytic activity, tended to return to normal gradually while FDP increased markedly. Fibrinolytic activity measured by eugolobulin lysis time remained low, suggesting depletion of vascular activator. Plasminogen level began to fall gradually 6 hr after cessation of the lactic acid infusion.

These dynamic coagulo-fibrinolytic changes are discussed in relation to the morphological changes of thrombi.

 

  • References

  • 1 Abiko Y, Iwamoto M, Shimizu M. Plasminogen-Plasmin System I. Purification and properties of human plasminogen. Journal of Biochemistry 1968; 64: 743
    PubMedGoogle Scholar
  • 2 Asada T, Igarashi M, Urita Y, Awazu S, Takeuchi S, Matsumoto M, Moroi M. A new technique for plasmin determination using affinity chromatography in the comparison with other methods. Journal of The Medical Society of Toho University 1972; 19: 549
    PubMedGoogle Scholar
  • 3 Bicher H. I, Beemer A. Prevention by an antiadhesive drug of thrombosis caused by blood cell aggregation. Angiology 1971; 21: 413
    PubMedGoogle Scholar
  • 4 Broersma R. J, Bullemer G. D, Mammen E. F. Blood coagulation changes in hemorrhagic shock and acidosis. Thrombosis et Diathesis Haemorrhagica Supplement 1969; 36: 171
    PubMedGoogle Scholar
  • 5 Broersma R. J, BUllemer G. D, Mammen E. F. Acidosis induced disseminated intravascular microthrombosis and its dissolution by streptokinase. Thrombosis et Diathesis Haemorrhagica 1970; 24: 55
    PubMedGoogle Scholar
  • 6 Busch C, Saldeen T. Amount of fibrin in difference organs after intravenous, intraportal and intraaortal injection of thrombin in the rat. Thrombosis et Diathesis Haemorrhagica 1973; 29: 87
    PubMedGoogle Scholar
  • 7 Guseinov C. S, Rakhmaeva V. A, Rabinovich Y. Y, Chistyakov V. N. Participation of the lung in the process of fibrinolysis. Soviet Medicine 1971; 34: 18
    PubMedGoogle Scholar
  • 8 Hartert H. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren. Klinische Wochenschrift 1948; 26: 577
    CrossrefPubMedGoogle Scholar
  • 9 Hladovec J. Experimental arterial thrombosis in rats with continuous registration. Thrombosis et Diathesis Haemorrhagica 1971; 26: 407
    PubMedGoogle Scholar
  • 10 Iwamoto M, Abiko Y. Plasminogen-Plasmin System. IV. Preparation of α2-macroglobulin antiplasmin from human plasma. Biochimica et Biophysica Acta 1971; 133: 374
    PubMedGoogle Scholar
  • 11 Langdell R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting time. Journal of Laboratory and Clinical Medicine 1953; 47: 637
    PubMedGoogle Scholar
  • 12 Lowry O. H, Rosebrough N. J, Farr A. L, Randwall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265
    PubMedGoogle Scholar
  • 13 Margaretten W, Csavossy L, McKay D. G. An electron microscopic study of thrombin induced disseminated intravascular coagulation. Blood 1967; 29: 169
    PubMedGoogle Scholar
  • 14 McKay D. G, Linder M. M, Cruse V. K. Mechanisms of thrombosis of the microcirculation. American Journal of Pathology 1971; 63: 231
    PubMedGoogle Scholar
  • 15 Merskey C, Kleiner G. J, Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 1966; 28: 1
    PubMedGoogle Scholar
  • 16 Nordöy A, Chandlar A. B. Platelet thrombosis induced by adenosine diphosphate in the rat. Scandinavian Journal of Haematology 1964; 1: 16
    PubMedGoogle Scholar
  • 17 Norman P. S. Antiplasmins. Federation Proceedings 1966; 25: 63
    PubMedGoogle Scholar
  • 18 Pflug J, Calnan J, Olsen G. J. An experimental model for the study of thrombosis. British Journal of Surgery 1968; 25: 63
    PubMedGoogle Scholar
  • 19 Quick A. J, Stanly B. M, Bancroft F. W. A study of the coagulation defect in hemophilia and in jaundice. American Journal of Medical Sciences 1935; 190: 501
    CrossrefPubMedGoogle Scholar
  • 20 Rapaport S. I, Schiffman S, Patch J, Ware A. G. Simple, specific one-stage assay for plasma thromboplastin antecedent activity. Journal of Laboratory and Clinical Medicine 1961; 57: 771
    PubMedGoogle Scholar
  • 21 Renaud S. Endotoxin-induced hepatic vein thrombosis in hyperlipemic rats. Sequence of events. Laboratory Investigation 1965; 14: 424
    PubMedGoogle Scholar
  • 22 Roschlau W. H. E, Painter R. H. Human fibrinolysin with and without urokinase: its effect on experimental arterial thrombi in dog. Canadian Journal of Biochemistry and Physiology 1962; 40: 1819
    CrossrefPubMedGoogle Scholar
  • 23 Rø J. S, Flatmark A. Studies on thrombin infusion in dogs. Scandinavian Journal of Haematology 1972; 9: 293
    PubMedGoogle Scholar
  • 24 Saldeen T. Experimental investigation on fat embolism and intravascular coagulation. Acta pathologica et microbiologica Scandinavia 1966; 66: 271
    PubMedGoogle Scholar
  • 25 Salzman E. W. Measurement of platelet adhesiveness. Journal of Laboratory and Clinical Medicine 1963; 62: 724
    PubMedGoogle Scholar
  • 26 Steinbuch M, Blatrix C, Josso F. α2-Macrogiobulin as progressive antithrombin. Nature 1967; 216: 500
    CrossrefPubMedGoogle Scholar
  • 27 Shahbudin H. R, Raphael M. J. Therapeutic defibrination and heparin therapy in the prevention and resolution of experimental venous thrombosis. Circulation 1970; 42: 729
    CrossrefPubMedGoogle Scholar
  • 28 Speer R. J, Ridgway H. The formation and decay of XIIa . Thrombosis et Diathesis Haemorrhagica 1967; 18: 259
    PubMedGoogle Scholar
  • 29 Stefanini M, Dameshek W. The Hemorrhagic Disorders. Grune & Stratton; New York: 1955: 149
    Google Scholar